In addition, University of Chicago doctors hold leadership positions in two national cooperative clinical
oncology research groups — the American College of Surgeons Oncology Group (ACOSOG) and the Alliance for Clinical Trials in Oncology.
Dr Gerrit - Jan Liefers (MD, PhD), a surgical oncologist and head of the geriatric
oncology research group at Leiden University Medical Centre (Leiden, The Netherlands), said: «For a screening program to be effective, one would expect that the incidence of early stage breast cancer would increase while the incidence of advanced stage cancer would decrease because any cancer would have been detected at an earlier stage.
I am a prominent member of clinical co-operative groups including the Children's Oncology Group (COG), Canadian Blood and Marrow Transplantation Group (CBMTG), Chronic GHVD Consensus Group (NIH sponsored), and C17 (a Canadian pediatric
oncology research group).
Not exact matches
Professor Paolo Boffetta (MD), the Annals of
Oncology associate editor for epidemiology and Director of the Institute of Translational Epidemiology at the Icahn School of Medicine at Mount Sinai in New York (USA), commented: «These results are extremely important in showing that reducing cancer mortality can be achieved: priority should be given to
research in cancers with unfavourable trends, such as pancreatic cancer, and in reducing cancer mortality disparities, both between countries (Central / Eastern versus Western Europe), and within countries, for example, between socioeconomic
groups.
Principal investigator E. Shelley Hwang, M.D., chief of breast surgery at the Duke Cancer Institute and vice chair of
research in the Duke University Department of Surgery, will lead the study through the cooperative
group, The Alliance for Clinical Trials in
Oncology.
Now in the second year of her PhD in Silvio Parodi's experimental
oncology group at the National Institute for Cancer
Research in Genoa, Stefania Pasa (see photo) was a studious child who often «preferred to... study rather than go out to the cinema.»
This was possible through the collaboration with
research groups from the School of Medicine at New York University (USA), the department of Biochemistry of the University of Würzburg (Germany) and the department of
Oncology of the University of Lausanne (Switzerland).
The
research group led by Prof. Achim Krüger at the Institute for Molecular Immunology and Experimental
Oncology of Klinikum rechts der Isar has now been able to explain this contradiction experimentally, thus shedding light on a mechanism that leads to the formation of metastases in the liver.
Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic
Oncology Group (GOG), a National Cancer Institute - supported
research network, in the January 5, 2006 issue of the New England Journal of Medicine.
The researchers are organized in different expert focus
groups, based on their expertise in different cancer types and
research areas in immuno -
oncology.
In addition to Doñana Biological Station (EBD - CSIC), also taking part in the project were the National Center for Genomic Analysis (CNAG - CRG); the Centre for Genomic Regulation (CRG); the Spanish National Cancer
Research Center (CNIO); the Evolutionary Genomics
Group of the Hospital del Mar Medical
Research Institute (IMIM); the Institute of Evolutionary Biology (IBE, CSIC - UPF); the University Institute of
Oncology of Asturias (IUOPA); the Institut de Biotecnologia i de Biomedicina and the Unit of Cell Culture of the Autonomous University of Barcelona (UAB); the Biological
Research Center (CIB - CSIC) and the Catalan Institution for
Research and Advanced Studies (ICREA).
Before he joined Moderna in 2013, Dr. Frederick was a Translational
Research group leader at Aveo
Oncology, focused on the generation of biomarkers for therapeutic response prediction, as well as avenues to modulate the tumor microenvironment for therapeutic benefit.
Based on our findings, the occurrence of cancer is much higher in adults over 75 years of age compared with the proportion of patients in this age
group who enroll in clinical trials,» said lead study author Bindu Kanapuru, MD, medical officer in the Division of Hematology Products, Office of Hematology and
Oncology Products in the US Food and Drug Administration's (FDA) Center for Drug Evaluation and
Research, who presented the results at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9 — 12 in Atlanta.
Previous
research (the Gynecologic
Oncology Group's GOG181B trial) has suggested that trastuzumab is inactive in HER2 / neu - expressing endometrial carcinomas, and in the current study, nearly half of the participants «ultimately did not have tumoral HER2 / neu gene amplification,» Dr. Santin said.
Dr. Zaks began his industry career at GlaxoSmithKline in the genetics
research group, where he built the
oncology translational medicine team and led translational
research on lapatinib as well as the in - licensing and clinical development of foretinib.
Together, this translational program is developed within the National Cancer and Cognition Platform (CNO / Ligue Nationale contre le cancer), with the aim to collaborate in a structured way with French
oncology groups,
research teams as well as pharmaceutical industry, by providing preclinical models and guidance on standard operating procedures for ancillary or future studies in identified population at risk.
The Indianapolis - based Hoosier
Oncology Group will serve as the administrative headquarters for the Big Ten Cancer
Research Consortium.
American Academy of Pediatrics (AAP) American Society of Clinical
Oncology (ASCO) American Association of Cancer
Research (AACR) American Society of Pediatric Hematology /
Oncology (ASPHO) Children's
Oncology Group (COG) Texas Pediatric Society (TPS) International Society of Paediatric
Oncology (SIOP) Connective Tissue
Oncology Society (CTOS)
We are part of a National Cancer Institute - funded Specialized Programs of
Research Excellence (SPORE) grant and participate in Children's
Oncology Group and internal lymphoma studies within Texas Children's Cancer Center and the Cell and Gene Therapy Program.
He is a member of the Children's
Oncology Group Subcommittee for Soft Tissue Sarcoma and the American Association for Cancer
Research.
He served as member of the Experimental Therapeutics - 2 NIH Study Section (1998 - 2003), the NCI Board of Scientific Counselors (1999 - 2004), NCI Parent Subcommittee A for review of Cancer Centers (2004 - 2008), the Breast Core Committee of the Eastern Cooperative
Oncology Group (ECOG), and the Board of Directors of the American Association for Cancer
Research (2004 - 2007).
Since 1990, Cohn has been a leader in national pediatric cooperative clinical
research groups, including serving as chair of the Pediatric
Oncology Group Neuroblastoma Biology Committee, chair of the Children's
Oncology Group (COG) Neuroblastoma Disease Committee, and director of the COG Neuroblastoma Tracking Center.
These include studies that are sponsored by the Eastern Cooperative
Oncology Group (ECOG), the Gynecologic
Oncology Group, the AIDS Malignancy Consortium and Accelerated Clinical
Oncology Research Network (ACORN).
Funding for the
research was provided by The Lyla Nsouli Foundation, the Children's
Oncology Group, the DIPG Collaborative (The Cure Starts Now Foundation, Reflections of Grace Foundation, Smiles for Sophie Foundation, Cancer - Free Kids Foundation, Carly's Crusade Foundation, Jeffrey Thomas Hayden Foundation, Soar with Grace Foundation), Accelerate Brain Cancer Cures Foundation, CureSearch for Childhood Cancer, and the Team Julian Foundation.
Current address: Department of Radiation
Oncology, Ludwig - Maximilians - Universität München, Munich, Germany; Clinical Cooperation
Group «Personalized Radiotherapy of Head and Neck Cancer», Helmholtz Center Munich - German
Research Center for Environmental Health (GmbH), Munich, Germany
Based on interviews and focus
groups conducted across the state, a business plan was developed for the Georgia Center for
Oncology Research and Education.
Dr. Cohn has held several leadership positions in national pediatric cooperative clinical
research groups, including serving as chair of the Children's
Oncology Group (COG) Neuroblastoma Disease Committee and she was a member of the COG Executive committee.
Director, Michael Cuccione Childhood Cancer
Research Program, BC Children's Hospital Co-Lead, Childhood Cancer & Blood
Research Group, BC Children's Hospital Professor, Division of Hematology and
Oncology, Department of Pediatrics, University of British Columbia
The Cancer Imaging and Radiobiology
Research Program continues to thrive as a multidisciplinary
group of cancer researchers that includes faculty from The Geisel School of Medicine at Dartmouth, the Thayer School of Engineering, and the clinical departments of Medicine (Radiation
Oncology), Surgery, and Radiology within Dartmouth - Hitchcock Medical Center (DHMC).
This grant has been used by the Veterinary Cooperative
Oncology Group to facilitate the sharing of
research results between the universities, clinics and veterinary oncologists who are conducting studies on the prevention and treatment of pet cancer.
«This important
research will measure the impact of animal - assisted therapy on pediatric
oncology patients and their families, thus furthering the fields of
research on human - animal interaction and integrated therapies for conditions such as cancer in children,» said J. Michael McFarland, DVM, Diplomate ABVP and
Group Director of Veterinary Medical Services & Corporate Citizenship for Pfizer Animal Health.